EDIT实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (27 Jun 2024 @ 00:33):
Our systems believe the stock currently is undervalued by 0.18% compare to its pairs and should correct upwards.

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases...

Stats
今日成交量	1.03M
平均成交量	2.06M
市值	398.53M
EPS	$-0.760 ( Q1 \| 2024-05-08 )
下一个收益日期	( $-0.660 ) 2024-07-31
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.34 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00800 (0.17%)

AADI -3.24%

ABCL 1.65%

ABCM 0.04%

ABEO -2.61%

ABIO -3.08%

ABOS 0.70%

ABSI 1.87%

ABUS -1.80%

ABVX -1.50%

ACAD -0.51%

ACER -17.95%

ACET -4.76%

ACGN 1.29%

ACHL 1.59%

ACHV -1.29%

ACIU -0.75%

ACLX 0.67%

ACRV -2.31%

ACST -2.90%

ACXP 1.38%

ADAG 4.64%

ADAP -4.05%

ADGI 0.87%

ADIL 1.75%

ADMA -2.09%

ADPT 0.15%

ADTX -2.38%

ADVM -3.62%

ADXN -1.60%

AEON -2.94%

AEZS -2.49%

AFMD -2.01%

AGEN -1.82%

AGIO -2.39%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 0.57%

AKRO -3.30%

AKTX 1.45%

AKUS 0.00%

ALBO 0.00%

ALDX -2.10%

ALEC 0.88%

ALGS -0.74%

ALKS 0.33%

ALLK -10.13%

ALLO -5.63%

ALLR -0.48%

ALNA 3.16%

ALNY 2.53%

ALPN 0.02%

ALPX 0.00%

ALRN -1.33%

ALT -9.25%

ALVR 2.60%

ALXN 0.00%

ALXO -13.24%

ALZN 5.27%

AMRN -1.68%

AMTI -3.13%

ANAB 1.45%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX 0.76%

ANPC -3.15%

APGE -0.07%

APGN 8.48%

APGNW 30.65%

APLM -2.22%

APLS 0.29%

APLT -3.04%

APM 0.36%

APOP 0.38%

APRE 0.60%

APTO 5.98%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -4.80%

ARDS -14.23%

ARDX 0.25%

ARGX -0.91%

ARNA 0.00%

ARPO -0.90%

ARQT -0.68%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.07%

ARWR -0.71%

ASLN -3.83%

ASMB -5.81%

ASND -1.74%

ATAI -2.22%

ATHA 5.02%

ATHE 0.56%

ATHX -33.50%

ATNF 4.29%

ATOS 2.43%

ATRA 0.79%

ATXI -2.78%

ATXS -0.22%

AUPH -0.99%

AURA 2.79%

AUTL -1.72%

AVBP -1.89%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -3.48%

AVTX -1.25%

AVXL -3.98%

AXLA 0.00%

AXSM -1.08%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.64%

BCAB 5.56%

BCDA -2.23%

BCDAW -41.77%

BCEL 0.00%

BCLI 4.36%

BCRX 0.41%

BCTX 8.90%

BCTXW -16.32%

BCYC 0.80%

BDRX -4.62%

BDTX -1.30%

BEAM 1.20%

BFRA -2.91%

BGNE -2.78%

BIOR -6.17%

BIVI 3.41%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.78%

BLU 0.03%

BLUE 0.47%

BMEA -11.04%

BMRN 0.07%

BNOX 6.22%

BNTC -0.42%

BNTX -1.59%

BOLD -12.19%

BOLT -0.05%

BPMC -1.14%

BPTH 0.00%

BPTS -13.47%

BRNS 0.00%

BRTX -3.52%

BTAI 24.25%

BTTX 50.67%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 4.24%

CABA 1.73%

CADL -2.12%

CALA 0.00%

CALC -1.77%

CALT -1.59%

CAPR -1.72%

CARA -0.06%

CARM 13.52%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -4.78%

CCCC -6.05%

CCXI 0.00%

CDAK 0.00%

CDIO -2.18%

CDIOW 24.00%

CDMO -2.96%

CDMOP 0.04%

CDT -4.84%

CDTTW -39.60%

CDTX -1.31%

CDXC 1.03%

CDXS 7.58%

CELC -4.21%

CELU -1.00%

CELUW 11.80%

CERC -1.68%

CERE -1.42%

CERO -3.67%

CEROW -21.56%

CFRX -27.95%

CGEM -2.98%

CGEN -3.31%

CGON -1.40%

CGTX -3.43%

CHMA -6.00%

CHRS 1.89%

CINC 0.00%

CING -2.73%

CINGW 34.95%

CKPT -3.37%

CLBS -16.75%

CLDX -1.22%

CLGN 0.34%

CLLS -4.15%

CLNN 0.00%

CLNNW 0.00%

CLRB 6.30%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 0.00%

CMPI 0.00%

CMPX -1.41%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.48%

CNCE 0.00%

CNSP -35.92%

CNST 0.00%

CNTA -0.28%

CNTB 0.00%

CNTX -7.31%

COCP -2.00%

COEPW 32.45%

COGT -3.37%

CORT 2.75%

COYA -1.46%

CPRX -1.12%

CRBP -3.49%

CRBU -6.53%

CRDF -0.89%

CRGX -0.07%

CRIS -1.72%

CRNX -5.93%

CRSP 0.63%

CRTX 2.63%

CRVO -5.75%

CRVS 1.69%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -4.12%

CTNM -2.21%

CTXR 3.00%

CUE 5.84%

CVAC -5.51%

CVKD -2.85%

CWBR 2.80%

CYAD -12.96%

CYCC 9.09%

CYCCP 5.49%

CYCN -0.24%

CYT -2.27%

CYTK -2.07%

CYTO -1.82%

DARE 4.02%

DAWN -1.04%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 27.93%

DNLI -1.45%

DNTH -10.07%

DOMH 2.43%

DRMA -4.04%

DRMAW -1.25%

DRNA 0.00%

DRTS 3.45%

DRTSW 0.00%

DRUG 0.95%

DSGN -2.87%

DTIL 1.99%

DYAI 12.26%

EARS -1.77%

EDIT -2.49%

EDSA 3.49%

EFTR 5.11%

EFTRW -51.85%

EIGR -9.21%

ELAB -2.84%

ELDN 8.99%

ELEV -6.64%

ELOX -5.38%

ELTX -4.26%

ELVN -4.15%

ELYM 2.23%

ENGN -1.42%

ENGNW 0.00%

ENLV 2.90%

ENOB 1.79%

ENSC 3.23%

ENTA 0.08%

ENTO -2.42%

ENTX 1.60%

ENVB 2.24%

EPIX -2.36%

EPRX -1.15%

EPZM 0.00%

EQ 0.32%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -3.82%

ETON 1.83%

ETTX 0.00%

EVAX -2.14%

EVGN 4.76%

EVLO 0.00%

EWTX -0.40%

EXAI -1.13%

EXEL -0.02%

EYEG -0.69%

EYEN 1.41%

EYPT 0.36%

FATE -10.09%

FBIO 0.89%

FBIOP -0.37%

FBLG -15.40%

FBRX -0.02%

FDMT -3.43%

FENC -1.29%

FGEN -7.69%

FHTX 6.87%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -1.27%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.40%

FULC -3.51%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.28%

GANX -2.31%

GBIO -2.83%

GBT 0.01%

GDTC 0.50%

GERN -4.64%

GHRS -2.30%

GLMD -5.00%

GLPG -2.11%

GLSI 1.43%

GLTO -2.16%

GLUE -3.17%

GLYC -10.12%

GMAB -0.66%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -3.14%

GNLX -0.22%

GNPX 1.47%

GNTA 3.94%

GOSS -10.71%

GOVX 0.00%

GOVXW -49.04%

GPCR -7.21%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 1.48%

GRTX 5.14%

GTHX 0.68%

GUTS -4.39%

GXGXW 41.67%

GYRE -8.82%

HALO -1.34%

HARP 0.09%

HCWB -3.75%

HEPA -4.09%

HGEN -84.62%

HILS 5.66%

HLVX 0.15%

HOOK 2.33%

HOTH -3.51%

HOWL -1.50%

HRMY 2.03%

HRTX 4.26%

HSTO 0.00%

HUMA 0.51%

HUMAW -0.01%

IBRX -4.13%

ICCC -1.55%

ICPT 0.21%

ICU 19.34%

ICUCW 20.46%

ICVX -0.91%

IDRA -23.04%

IDYA -1.80%

IFRX -1.85%

IGMS -0.51%

IKNA 1.19%

IKT -0.35%

IMAB 2.33%

IMCR -2.88%

IMGN 0.02%

IMGO 0.00%

IMMP 3.99%

IMMX -8.19%

IMNM 0.52%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX 0.00%

IMTX -0.58%

IMTXW 6.00%

IMUX 1.85%

IMV 0.00%

IMVT -4.91%

INAB -0.01%

INBX 0.53%

INCY -1.33%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 1.49%

INMB 1.82%

INO -1.37%

INSM -1.45%

INTS -2.75%

INVA 0.55%

INZY 0.80%

IOBT -10.34%

IONS 0.91%

IOVA -3.55%

IPA -0.49%

IPHA 5.58%

IPSC -2.54%

IRON -1.77%

ISEE 0.38%

ITOS -1.68%

ITRM 1.67%

IVA 6.96%

IVVD -2.89%

JAGX 1.18%

JANX -3.93%

JAZZ -0.66%

JNCE 0.00%

JSPR -5.53%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -5.80%

KDNY 0.22%

KMPH -0.34%

KNSA -2.08%

KNTE -0.38%

KOD -6.53%

KPRX 0.96%

KPTI -5.05%

KRBP -10.00%

KRON 0.58%

KROS -1.07%

KRRO -8.11%

KRTX 0.03%

KRYS -0.37%

KTRA 9.42%

KTTA -6.79%

KTTAW 0.92%

KURA -0.24%

KYMR -2.95%

KYTX -3.88%

KZIA 2.65%

KZR -0.85%

LABP 0.57%

LBPH -1.75%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.75%

LENZ -5.09%

LEXX -0.77%

LEXXW -14.63%

LGND -0.50%

LGNDV 0.00%

LGVN -7.61%

LIAN -8.28%

LIFE 2.70%

LIPO -3.87%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.39%

LPCN -1.86%

LPTX -2.75%

LQDA -0.19%

LRMR -2.06%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.03%

LXEO -4.08%

LXRX -2.06%

LYEL -36.59%

LYRA 1.16%

MACK 0.10%

MBIO -8.92%

MBRX -1.72%

MCRB 2.46%

MDGL -1.29%

MDNA -13.16%

MDWD -0.14%

MDXG -2.58%

MEIP 1.40%

MESO -1.26%

MGNX -2.10%

MGTA -7.74%

MGTX -3.61%

MGX -4.02%

MIRM -0.83%

MIRO 0.59%

MIST 1.15%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX 0.25%

MLYS -7.53%

MNKD 0.29%

MNMD 0.14%

MNOV 2.11%

MNPR -8.52%

MOLN 2.46%

MOR 1.20%

MORF -3.31%

MREO -2.86%

MRKR 2.57%

MRNA -6.04%

MRNS -4.40%

MRSN -2.14%

MRTX -0.17%

MRUS 0.19%

MRVI -1.16%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -0.93%

MYMD 7.08%

NAMS 3.32%

NAMSW -0.21%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.73%

NERV -0.63%

NEXI 1.84%

NGM -1.28%

NGNE -1.16%

NKGN 10.08%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.90%

NLSP 5.88%

NLSPW 26.67%

NMRA -2.86%

NMTR -42.97%

NOVN -24.84%

NRBO 7.04%

NRIX -2.45%

NRSN -5.12%

NRSNW 0.00%

NRXP -3.72%

NRXPW 18.33%

NRXS 4.82%

NTBL 3.99%

NTEC -12.45%

NTHI 0.00%

NTLA -6.79%

NTRBW -31.07%

NUVL -1.89%

NVAX -2.14%

NVCT 3.55%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 1.32%

OABIW -10.06%

OBIO -2.92%

OBSV 0.00%

OCEA 0.00%

OCGN 2.12%

OCS -1.00%

OCUL 0.15%

OCUP 1.30%

ODT -4.27%

OKYO 1.51%

OLMA -5.29%

OMER -1.16%

OMGA 5.64%

ONCO 4.04%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY 0.99%

ONTX -0.47%

ONVO 1.32%

OPNT 0.00%

OPT 3.09%

ORGS 0.96%

ORIC -3.42%

ORMP 17.83%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.23%

OVID 1.43%

OYST 0.00%

PALI 1.30%

PASG -1.30%

PBLA -7.50%

PBM -3.48%

PBYI 1.18%

PCSA 0.00%

PCVX -0.34%

PDSB -3.16%

PEPG 1.37%

PGEN -2.40%

PHAR 1.51%

PHAS 0.00%

PHAT -1.40%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.32%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.47%

PLUR 7.39%

PMN 0.72%

PMVP -0.89%

PNT 0.16%

PPBT -6.35%

PRAX 3.14%

PRDS 0.93%

PRLD -2.37%

PROG -3.47%

PROK 0.00%

PRQR -0.66%

PRTA -2.41%

PRTC 0.49%

PRTG 7.02%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -10.46%

PSTX -1.16%

PTCT -0.46%

PTE -0.82%

PTGX -0.87%

PTIXW -48.41%

PULM 2.60%

PXMD 4.76%

PYPD 0.07%

PYXS 0.33%

QLGN -3.00%

QNCX 5.70%

QNRX -1.14%

QSI -11.21%

QSIAW -3.13%

QTTB -3.39%

QURE -0.78%

RAIN -1.63%

RANI 6.42%

RAPT -1.30%

RARE 1.54%

RCKT -8.70%

REGN 0.29%

RENB -3.11%

REPL -2.49%

RETA 0.02%

REUN -0.89%

REVB -2.79%

REVBU 3.46%

REVBW 5.00%

RGLS -6.78%

RGNX -5.88%

RIGL -3.29%

RLAY -3.86%

RLMD 0.35%

RLYB -1.34%

RNA 0.62%

RNAC -2.94%

RNAZ -1.92%

RNXT 0.89%

ROIV -2.08%

ROIVW 4.56%

RPHM -0.93%

RPRX 0.28%

RPTX -0.29%

RUBY 2.70%

RVLP -32.05%

RVMD -1.03%

RVMDW -30.00%

RVNC 0.21%

RVPH -1.98%

RVPHW 1.62%

RXDX 0.09%

RXRX -4.26%

RYTM -5.59%

RYZB 0.02%

RZLT 3.10%

SABS -1.37%

SABSW -11.81%

SAGE 1.24%

SANA -3.87%

SAVA -0.16%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -0.06%

SCPH 5.32%

SCPS 0.00%

SEEL -4.08%

SEER 0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -0.38%

SGMT -2.42%

SGTX -2.56%

SIOX 22.63%

SLDB -9.14%

SLGL 4.12%

SLN -4.42%

SLNO -4.34%

SLRX 5.27%

SLS -1.71%

SMMT -1.37%

SNDX 1.18%

SNGX -4.91%

SNPX -4.39%

SONN 0.00%

SPPI -0.49%

SPRB 0.63%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -0.98%

SRRA 0.00%

SRRK -2.11%

SRZN -2.45%

STAB 0.00%

STOK -5.52%

STRO -3.34%

STSA 0.00%

STTK -1.69%

SURF -0.93%

SVRA -8.02%

SWTX -0.19%

SYBX -1.29%

SYRS -1.55%

TALS -0.73%

TARA -7.62%

TARS 0.25%

TBPH 0.54%

TCBP 2.48%

TCDA 0.00%

TCON 2.46%

TCRR 0.00%

TCRT 0.08%

TCRX -1.45%

TECH -0.08%

TENX 1.91%

TERN -8.55%

TFFP -5.33%

TGTX -4.38%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -4.60%

TNGX -3.83%

TNXP -5.65%

TNYA -4.73%

TPST 5.24%

TRDA -4.06%

TRVI 2.30%

TRVN 4.12%

TSHA -22.76%

TSVT -3.46%

TTNP -7.66%

TVTX 1.75%

TYRA -8.54%

UBX -2.84%

UNCY -3.94%

URGN -1.15%

UTHR 0.56%

VACC 11.36%

VALN -4.07%

VAXX 118.35%

VBIV 0.33%

VBLT -8.77%

VCEL 0.96%

VCNX 10.35%

VCYT -1.61%

VERA -4.20%

VERU 0.98%

VERV -2.96%

VIGL 4.84%

VINC 2.28%

VIR 0.98%

VIRI -1.73%

VIRX 3.15%

VKTX -1.49%

VLON -13.04%

VNDA -3.42%

VOR -1.61%

VRCA 0.07%

VRDN -4.70%

VRNA -0.47%

VRPX 0.38%

VRTX 0.28%

VSTM -1.53%

VTGN -1.81%

VTVT -2.97%

VTYX -2.08%

VXRT -4.88%

VYGR -0.26%

VYNE -4.62%

VYNT 7.78%

WINT 2.18%

WVE -6.29%

XBIO 1.03%

XBIT -2.05%

XCUR 3.55%

XENE -0.97%

XERS 2.62%

XFOR 4.17%

XLO 3.88%

XLRN 0.00%

XNCR 0.40%

XOMA -3.22%

XOMAO -0.16%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.72%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.80%

ZNTL -2.14%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-04	O'neill Gilmore Neil	Sell	12 191	Common Stock
2024-06-04	Mei Baisong	Sell	511	Common Stock
2024-05-30	Scadden David	Buy	25 000	Stock Option (right to buy)
2024-05-30	Hopfield Jessica	Buy	25 000	Stock Option (right to buy)
2024-05-30	Chatterjee Meeta	Buy	25 000	Stock Option (right to buy)

INSIDER POWER
86.08
Last 95 transactions
Buy: 4 215 987 \| Sell: 170 049

相关性 (AI algo v.1.1b): Undervalued: 0.18% $4.86 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

音量相关性

長: 0.00 (neutral)

短: 0.02 (neutral)

Signal:(59.971) Neutral

Editas Medicine Inc 相关性

10 最正相关
BROG	0.915
RKDA	0.913
NEOG	0.905
CDZI	0.896
WKHS	0.894
HUGE	0.892
JWEL	0.892
TXG	0.882
BMRA	0.881
MIRM	0.88

10 最负相关
IVCB	-0.871
KEQU	-0.869
SOHU	-0.843
PTMN	-0.836
GAIA	-0.834
BSCO	-0.829
NHTC	-0.828
IMPP	-0.828
WIRE	-0.827
BCSA	-0.827

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Editas Medicine Inc 相关性 - 货币/商品

-0.25
( neutral )

0.01
( neutral )

0.00
( neutral )

-0.13
( neutral )

Editas Medicine Inc 财务报表

Annual	2023
营收:	$78.12M
毛利润:	$72.06M (92.24 %)
EPS:	$-2.02

FY	2023
营收:	$78.12M
毛利润:	$72.06M (92.24 %)
EPS:	$-2.02

FY	2022
营收:	$19.71M
毛利润:	$13.38M (67.85 %)
EPS:	$-2.98

FY	2021
营收:	$25.54M
毛利润:	$0.00 (0.00 %)
EPS:	$-2.85

Financial Reports:

No articles found.

Editas Medicine Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Editas Medicine Inc

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads to inherited childhood blindness. It also develops EDIT-102 for the treatment of Usher Syndrome 2A, which is a form of retinitis pigmentosa that also includes hearing loss; autosomal dominant retinitis pigmentosa, a progressive form of retinal degeneration; and EDIT-301 to treat sickle cell disease and transfusion-dependent beta-thalassemia. In addition, the company is developing gene-edited Natural Killer cell medicines to treat solid tumor cancers; alpha-beta T cells for multiple cancers; and gamma delta T cell therapies to treat cancer, as well as has an early discovery program to develop a therapy to treat a neurological disease. It has a research collaboration with Juno Therapeutics, Inc. to develop engineered T cells for cancer; strategic alliance and option agreement with Allergan Pharmaceuticals International Limited to discover, develop, and commercialize new gene editing medicines for a range of ocular disorders; and research collaboration with Asklepios BioPharmaceutical, Inc. to develop a therapy to treat a neurological disease, as well as research collaboration with AskBio. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.